ARCHIVES

Ibrutinib Increases OS, PFS Versus Ofatumumab in Phase III

This article is from The Cancer Letter archive.

Vol. 37 No. 6 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

Price Increase

July 22, 1983

NCAB Asks NCI To Delay Proposed change In Breast Cancer Screening Guidelines

November 26, 1993

Science Policy: Stem Cell Research Guidelines Formalize NIH Funding Polices

December 3, 1999

Bill Promotes Awareness Of Pediatric Cancer Research.

September 22, 2000

Xeloda, Taxotere, Herceptin Combination May Benefit Invasive Breast Cancer

January 25, 2008

Final Issue Of 1984

December 13, 1984